Alignment Healthcare
Medicare Advantage plans paired with data-driven care coordination for seniors.
Something off on this page? Send us feedback.
Profile
Sells Medicare Advantage plans for seniors, earning mainly fixed monthly CMS payments while assuming members' covered-care costs. AVA analytics, Care Anywhere clinical teams, provider networks, and concierge support coordinate care across a single healthcare-services segment.
Offers Medicare Advantage coverage to seniors through Alignment Health Plan, including HMO, PPO, and special-needs designs across selected markets in California, North Carolina, Nevada, Arizona, and Texas. Revenue comes mainly from fixed monthly CMS payments, while the insurer assumes responsibility for covered care and related costs.
Combines the AVA data platform with Care Anywhere clinical teams, local provider networks, the ACCESS On-Demand Concierge card, and round-the-clock member service to identify higher-risk members and coordinate care at home or remotely. Operates as one healthcare-services segment. The model depends on annually renewed CMS contracts, risk-adjusted payments and Star Ratings, accurate medical-cost forecasting, and provider-network performance.
Company facts
Categories
Key statistics
Year to date −32.6% · Average volume (30d) 5.3M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Raymond James | Downgrade | Strong Buy | Outperform | $22 | $19 |
| May 26, 2026 | Barclays | Reiterate | Equal Weight | $19 | $16 | |
| May 7, 2026 | Raymond James | Target | $10 | $22 | ||
| May 1, 2026 | UBS | Reiterate | Neutral | $21 | $22 | |
| May 1, 2026 | Barclays | Reiterate | Equal Weight | $18 | $19 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026Q2 FY26 | $0.13 | $0.17 | +31.8% | $1.31B | $1.34B | +2.0% | −20.20% |
| Apr 30, 2026Q1 FY26 | $0.01 | $0.05 | +400.0% | $1.22B | $1.24B | +1.4% | −10.12% |
| Feb 26, 2026Q4 FY25 | −$0.15 | −$0.05 | +66.7% | $1.00B | $1.01B | +0.9% | −5.88% |
| Oct 30, 2025Q3 FY25 | −$0.01 | $0.02 | +300.0% | $980.9M | $993.7M | +1.3% | −1.52% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $926.9M | $1.02B | $993.7M | $1.01B | $1.24B | $1.34B | |
| Gross profit | $106.0M | $133.5M | $125.7M | $123.3M | $144.5M | $181.0M | |
| Operating income | −$5.4M | $22.7M | $7.7M | −$10.3M | $15.5M | $42.1M | |
| Net income | −$9.1M | $15.7M | $3.7M | −$11.0M | $11.4M | $36.6M | |
| Diluted EPS | −$0.05 | $0.07 | $0.02 | −$0.05 | $0.05 | $0.17 | |
| Gross margin | 11.4% | 13.2% | 12.6% | 12.2% | 11.7% | 13.5% | |
| Operating margin | -0.6% | 2.2% | 0.8% | -1.0% | 1.3% | 3.2% |
Fiscal years (4-quarter sums)FY21 $1.17B · FY22 $1.43B · FY23 $1.82B · FY24 $2.70B · FY25 $3.95B
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $701.7M · Total debt $330.5M · Total assets $1.28B · Shareholders' equity $265.1M
Dividends
No dividends on record.
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 207.44M · Float 187.52M · 90.4% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 19.34M | 9.32% | 13F | Aug 7, 2026 |
| Wellington Management Group LLP | 18.78M | 9.05% | 13F | Aug 14, 2026 |
| FMR LLC | 13.92M | 6.71% | 13F | Aug 13, 2026 |
| General Atlantic, L.P. · 10 percent owner | 13.48M | 6.50% | Form 4 | Dec 12, 2025 |
| Qatar Investment Authority | 13.25M | 6.69% | 13G | Sep 24, 2025 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 14, 2026 | Dawn Christine Maroney | officer: President | −5,000 | $14.00 |
| Aug 10, 2026 | John E. Kao | director, officer: Chief Executive Officer | −298,000 | $13.88 |
| Jul 15, 2026 | Dawn Christine Maroney | officer: President | −177,068 | $20.83 |
| Jul 10, 2026 | John E. Kao | director, officer: Chief Executive Officer | −298,000 | $19.86 |
| Jul 1, 2026 | Joseph S. Konowiecki | director, officer: EVP, Corporate Affairs | −25,000 | $24.00 |
Peers
- UnitedHealth Group
Largest MA rival with national scale, Part D, and Optum support
- Humana
Senior-focused MA carrier with large value-based care membership
- CVS Health
Aetna MA plans add national pharmacy and PDP channel pressure
- Elevance Health
Anthem and Wellpoint MA networks challenge regional plan growth
- Centene
Wellcare overlaps in MA, PDP, and value-conscious senior plans
- Clover Health
Tech-enabled MA peer built around Clover Assistant
- Molina Healthcare
Dual-eligible Medicare operator with narrowing MAPD overlap
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Alignment Healthcare | $13.62 | −0.04% | $2.83B | 73.0 | 46.0 | 0.6 | +31.6% |
| UnitedHealth Group | $392.50 | −0.12% | $356.86B | 25.3 | 18.4 | 0.8 | +0.4% |
| Humana | $386.23 | +0.16% | $46.30B | 36.5 | 31.2 | 0.3 | +26.2% |
| CVS Health | $93.07 | +0.02% | $118.74B | 24.6 | 11.5 | 0.3 | +7.3% |
| Elevance Health | $397.30 | +0.72% | $85.54B | 17.5 | 14.5 | 0.4 | +0.1% |
| Centene | $64.94 | +0.28% | $31.99B | — | 14.3 | 0.2 | +9.9% |
| Clover Health | $4.22 | −0.12% | $2.19B | — | 60.1 | 0.9 | +55.6% |
| Molina Healthcare | $200.00 | −0.01% | $10.44B | 1,052.6 | 28.5 | 0.2 | −4.8% |
| Median | 25.3 | 18.4 | 0.3 | +7.3% |